Pharmena S.A. (WSE:PHR)
Poland · Delayed Price · Currency is PLN 3.340
+0.040 (1.21%)
Feb 24, 2026, 5:03 PM CET
Pharmena Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1.27 | 0.27 | 0.3 | 0.3 | 15.21 | 9.93 | |
Revenue Growth (YoY) | 313.64% | -10.37% | - | -98.04% | 53.16% | -10.51% |
Cost of Revenue | 0.2 | 0.07 | 0.3 | 0.21 | 6.79 | 3.55 |
Gross Profit | 1.08 | 0.2 | -0 | 0.09 | 8.43 | 6.38 |
Selling, General & Admin | 4.33 | 3.58 | 3.96 | 3.84 | 12.02 | 12.45 |
Other Operating Expenses | 0.01 | 0.03 | -36.77 | 0.31 | 0.47 | 0.07 |
Operating Expenses | 4.34 | 3.6 | -32.81 | 4.15 | 12.48 | 12.52 |
Operating Income | -3.26 | -3.4 | 32.81 | -4.06 | -4.05 | -6.14 |
Interest Expense | -0.02 | -0.04 | -0.37 | -0.66 | -0.27 | -0.2 |
Interest & Investment Income | 0.61 | 0.88 | 0.43 | - | - | - |
Currency Exchange Gain (Loss) | -0 | -0 | 0.07 | -0.01 | -0.04 | -0.02 |
Other Non Operating Income (Expenses) | - | - | -0.14 | -0.24 | -0.17 | -0.04 |
EBT Excluding Unusual Items | -2.67 | -2.56 | 32.8 | -4.97 | -4.53 | -6.4 |
Gain (Loss) on Sale of Investments | - | - | 0.03 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 0.02 | 0.01 | 0.04 | - |
Other Unusual Items | 0.01 | 0.01 | 0.08 | - | 0.03 | 0.12 |
Pretax Income | -2.66 | -2.56 | 32.93 | -4.95 | -4.46 | -6.27 |
Income Tax Expense | -0.47 | -1.3 | 5.91 | 0.2 | 0.18 | 0.69 |
Earnings From Continuing Operations | -2.2 | -1.26 | 27.02 | -5.16 | -4.64 | -6.96 |
Earnings From Discontinued Operations | - | - | 1.93 | 3.54 | - | - |
Net Income to Company | -2.2 | -1.26 | 28.95 | -1.62 | -4.64 | -6.96 |
Minority Interest in Earnings | - | - | -0.01 | 0.05 | 0.05 | 0.07 |
Net Income | -2.2 | -1.26 | 28.94 | -1.57 | -4.59 | -6.89 |
Net Income to Common | -2.2 | -1.26 | 28.94 | -1.57 | -4.59 | -6.89 |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 11 |
Shares Change (YoY) | - | - | - | - | 1.25% | 9.87% |
EPS (Basic) | -0.20 | -0.11 | 2.60 | -0.14 | -0.41 | -0.63 |
EPS (Diluted) | -0.20 | -0.11 | 2.60 | -0.14 | -0.41 | -0.63 |
Free Cash Flow | -2.85 | -2.71 | 32.72 | 1.59 | -3.54 | -2.45 |
Free Cash Flow Per Share | -0.26 | -0.24 | 2.94 | 0.14 | -0.32 | -0.22 |
Dividend Per Share | 0.850 | 0.850 | 0.850 | - | - | - |
Gross Margin | 84.54% | 73.88% | -0.33% | 30.44% | 55.39% | 64.23% |
Operating Margin | -256.20% | -1269.78% | 10972.91% | -1358.19% | -26.65% | -61.76% |
Profit Margin | -172.37% | -470.90% | 9679.26% | -525.08% | -30.19% | -69.38% |
Free Cash Flow Margin | -223.86% | -1011.57% | 10942.48% | 532.78% | -23.30% | -24.68% |
EBITDA | -3.22 | -3.38 | 32.88 | -3.95 | -3.86 | -5.81 |
EBITDA Margin | -252.83% | - | 10997.66% | - | -25.35% | -58.53% |
D&A For EBITDA | 0.04 | 0.02 | 0.07 | 0.11 | 0.2 | 0.32 |
EBIT | -3.26 | -3.4 | 32.81 | -4.06 | -4.05 | -6.14 |
EBIT Margin | -256.20% | - | 10972.91% | - | -26.65% | -61.76% |
Effective Tax Rate | - | - | 17.94% | - | - | - |
Advertising Expenses | - | 0.03 | 0.18 | 0.06 | 0.6 | 1.09 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.